Athos Therapeutics Inc.
- Biotech – food & agriculture
- Biotech or pharma, therapeutic R&D
- Other R&D services
Athos is a clinical stage biotech pioneering the development of Artificial Intelligence-based, first-in-class precision therapeutics for patients with IBD (entering a Phase 2 in UC with ATH-063), other autoimmune diseases, and cancer (novel MoA FLT3 program progressing to clinical testing). Looking for pharma partners, licensors, and funders interested in our drug assets and AI-powered omics platform. The Athos AI platform has been used in-house to develop multiple novel drug leads for various unmet medical needs. The platform can also leverage omics data across industries including agriculture, food and beverage, cosmetics, etc.



